Data / Form D filings / OurPharma Holdings LLC
OurPharma Holdings LLC: Form D filings
OurPharma Holdings LLC, a pharmaceuticals company in Fayetteville, AR, filed 9 Form D notices with the SEC between 2017 and 2026. The latest, on July 10, 2026, reports $500,000 sold of a $3.5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2512 S CITY LAKE RD, Fayetteville, AR, 72701
- Phone
- (479) 871-7341
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1725565
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Amendment | $3,450,000 | $500,000 | $2,950,000 | 3 | Jul 21, 2025 | sec.gov |
| Jul 23, 2025 | New notice | $3,450,000 | $250,000 | $3,200,000 | 1 | Jul 21, 2025 | sec.gov |
| Feb 20, 2024 | Amendment | $17,000,000 | $13,450,000 | $3,550,000 | 30 | Aug 9, 2019 | sec.gov |
| Feb 24, 2023 | Amendment | $17,000,000 | $10,450,000 | $6,550,000 | 19 | Aug 9, 2019 | sec.gov |
| Mar 10, 2022 | Amendment | $12,000,000 | $9,950,000 | $2,050,000 | 24 | Aug 9, 2019 | sec.gov |
| Oct 7, 2021 | Amendment | $9,000,000 | $5,500,000 | $3,500,000 | 13 | Aug 9, 2019 | sec.gov |
| Dec 10, 2020 | Amendment | $6,000,000 | $3,500,000 | $2,500,000 | 10 | Aug 9, 2019 | sec.gov |
| Aug 14, 2019 | New notice | $3,000,000 | $1,900,000 | $1,100,000 | 6 | Aug 9, 2019 | sec.gov |
| Dec 21, 2017 | New notice | $3,500,000 | $2,225,000 | $1,275,000 | 7 | Dec 19, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Kohler | Executive Officer, Director | |
| Adam Kohler | Executive Officer, Director | |
| Brooke Erwin | Director | |
| Todd Kohler | Director | |
| Michael Mauldin | Director | |
| Brent Beaulieu | Director |
Every Form D from the week of Jul 6, 2026 · All recent filings in Arkansas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what OurPharma Holdings LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.